Abstract
We evaluated the association between molecular subtypes of advanced gastric cancer (AGC) and the efficacy of standard chemotherapy or immune checkpoint inhibitors. Patients with AGC who received systemic chemotherapy from October 2015 to July 2018 with available molecular features were analyzed. We investigated the efficacy of standard first- (fluoropyrimidine + platinum ± trastuzumab) and second-line (taxanes ± ramucirumab) chemotherapy, and subsequent anti-PD-1 therapy in patients with four molecular subtypes: MMR-D (mismatch repair deficient), EBV+, HER2+, and all negative. 410 patients were analyzed: MMR-D 5.9%, EBV+ 4.1%, HER2+ 13.7%, and all negative 76.3%. In 285 patients who received standard first-line chemotherapy, the median progression-free survival (PFS) times were 4.2, 6.0, 7.5, and 7.6 months and the objective response rates (ORR) were 31%, 62%, 60%, and 49% in MMR-D, EBV+, HER2+, and all-negative subtypes, respectively. Multivariate analysis showed shorter PFS in MMR-D versus all-negative patients [HR, 1.97; 95% CIs, 1.09-3.53; P = 0.022]. In second-line setting, there were no significant differences in efficacy. In 110 patients who received anti-PD-1 therapy, median PFS times were 13.0, 3.7, 1.6, and 1.9 months...Continue Reading
References
Jun 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ian ChauPaul J Ross
Dec 4, 2004·Gastroenterology·Akihiro TajimaJohn M Carethers
Dec 22, 2004·The Journal of Biological Chemistry·Mark MeyersDavid A Boothman
Feb 15, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J LeeW K Kang
Aug 24, 2010·Lancet·Yung-Jue BangUNKNOWN ToGA Trial Investigators
Jul 12, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Peter C Thuss-PatiencePeter Reichardt
Mar 14, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jung Hun KangSe Hoon Park
Oct 8, 2013·Lancet·Charles S FuchsUNKNOWN REGARD Trial Investigators
Oct 9, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antonio C WolffUNKNOWN College of American Pathologists
Oct 11, 2013·Journal of the National Cancer Institute·Xavier PaolettiUNKNOWN GASTRIC group
Nov 6, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Shuichi HironakaIchinosuke Hyodo
Dec 18, 2013·The Lancet Oncology·Hugo E R FordUNKNOWN COUGAR-02 Investigators
Mar 29, 2014·The Oncologist·Daisuke TakahariAtsushi Ohtsu
Aug 1, 2014·Nature·UNKNOWN Cancer Genome Atlas Research Network
Sep 16, 2014·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayFreddie Bray
Sep 23, 2014·The Lancet Oncology·Hansjochen WilkeUNKNOWN RAINBOW Study Group
Oct 16, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·Y YamadaI Hyodo
Apr 22, 2015·Nature Medicine·Razvan CristescuAmit Aggarwal
Jun 2, 2015·The New England Journal of Medicine·Dung T LeLuis A Diaz
Oct 25, 2016·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·J-L Van LaethemTh Seufferlein
Sep 25, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E C SmythUNKNOWN ESMO Guidelines Committee
Jun 10, 2017·Science·Dung T LeLuis A Diaz
Oct 11, 2017·Lancet·Yoon-Koo KangLi-Tzong Chen
Nov 11, 2017·Cancer Discovery·Yelena Y JanjigianNikolaus Schultz
Nov 28, 2017·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Shona HendryStephen B Fox
Mar 16, 2018·JAMA Oncology·Charles S FuchsHarry H Yoon
Jun 3, 2018·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Akihito KawazoeTakeshi Kuwata
Jul 18, 2018·Nature Medicine·Seung Tae KimWon Ki Kang
Feb 2, 2019·Journal for Immunotherapy of Cancer·Saori MishimaKohei Shitara
May 16, 2019·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Taroh SatohNarikazu Boku
Jun 27, 2019·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F WangR H Xu
Sep 13, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Filippo PietrantonioElizabeth Catherine Smyth
Jan 29, 2020·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F WangR H Xu
Jan 1, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·Y YamadaI Hyodo
Citations
Jun 24, 2020·Cancer Medicine·Monika LaszkowskaChin Hur
Jul 16, 2020·Cancers·Mauricio P PintoMarcelo Garrido
Aug 28, 2020·Frontiers in Pharmacology·Xiaohao ZhengYibin Xie
Aug 11, 2020·Journal of Immunology Research·Siru Nie, Yuan Yuan
Nov 10, 2020·Internal Medicine·Yukino YatsudaYuji Mizokami
Nov 27, 2020·Japanese Journal of Clinical Oncology·Akihito KawazoeMasanori Terashima
Jan 20, 2021·Nature Reviews. Cancer·Shogo KumagaiHiroyoshi Nishikawa
Dec 17, 2020·International Journal of Molecular Sciences·Valli De ReRenato Cannizzaro
Apr 2, 2021·Nature Reviews. Clinical Oncology·Yoshiaki NakamuraKohei Shitara
Apr 2, 2021·JAMA Oncology·Joseph ChaoZev A Wainberg
Jun 4, 2021·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K ShitaraC S Fuchs
Jul 9, 2021·Oncoimmunology·Xiao-Li WeiYi-Hong Ling
Nov 13, 2020·Visceral Medicine·Angelica Petrillo, Elizabeth C Smyth